Back
Direxion Daily Travel & Vctn Bll 2X ETF Vs. ProShares Ultra Nasdaq Biotechnology Industry Stock Comparison
Buy
89
OOTO
Direxion Daily Travel & Vctn Bll 2X ETF
Last Price:
18.97
Seasonality Move:
15.58%
Sell
46
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
58.90
Seasonality Move:
13.85%
Buy
89
Direxion Daily Travel & Vctn Bll 2X ETF (OOTO)
is a Buy
Is Direxion Daily Travel & Vctn Bll 2X ETF a Buy, Sell or Hold?
- The current Direxion Daily Travel & Vctn Bll 2X ETF [OOTO] share price is $19.08. The Score for OOTO is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- OOTO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
46
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $61.75. The Score for BIB is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OOTO Stock Price Chart
What is Direxion Daily Travel & Vctn Bll 2X ETF's stock price today?
-
The Direxion Daily Travel & Vctn Bll 2X ETF share price today is $19.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OOTO is experiencing slight buying pressure.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $61.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing selling pressure, which indicates risk of future bearish movement.
OOTO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.88 | Buy |
Relative Strength Index (14 RSI): | 74.73 | Buy |
Chaikin Money Flow: | 790 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.42 - 18.3) | Buy |
Bollinger Bands (100): | (12.43 - 16.53) | Buy |
BIB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.12 | Buy |
Relative Strength Index (14 RSI): | 43.98 | Sell |
Chaikin Money Flow: | -16544 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (61.68 - 65.1) | Sell |
Bollinger Bands (100): | (61.18 - 66.64) | Sell |
OOTO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.49 | Buy |
20-day SMA: | 17.6 | Buy |
50-day SMA: | 15.87 | Buy |
200-day SMA: | 14.64 | Buy |
8-day EMA: | 18.57 | Buy |
20-day EMA: | 17.71 | Buy |
50-day EMA: | 16.3 | Buy |
200-day EMA: | 14.58 | Buy |
BIB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.13 | Sell |
20-day SMA: | 63.27 | Sell |
50-day SMA: | 63.75 | Sell |
200-day SMA: | 59.99 | Buy |
8-day EMA: | 63.69 | Sell |
20-day EMA: | 63.49 | Sell |
50-day EMA: | 63.53 | Sell |
200-day EMA: | 60.5 | Buy |
Direxion Daily Travel & Vctn Bll 2X ETF Earnings Growth & OOTO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Direxion Daily Travel & Vctn Bll 2X ETF Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ProShares Ultra Nasdaq Biotechnology Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |